Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease ; volume:13 ; number:1 ; day:29 ; month:4 ; year:2023 ; pages:1-7 ; date:12.2023
Scientific reports ; 13, Heft 1 (29.4.2023), 1-7, 12.2023
- Urheber
-
Martin-Arranz, M. D.
García-Ramírez, L.
Hernandez-Perez, M.
Montero Vega, D.
Martín-Arranz, E.
Sánchez-Azofra, M.
Poza Cordon, J.
Rueda Garcia, J. L.
Noci Belda, J.
Verges Martínez-Meco, T.
Blanco San Miguel, P.
Suarez Ferrer, C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-33402-w
- URN
-
urn:nbn:de:101:1-2023090510442079345424
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martin-Arranz, M. D.
- García-Ramírez, L.
- Hernandez-Perez, M.
- Montero Vega, D.
- Martín-Arranz, E.
- Sánchez-Azofra, M.
- Poza Cordon, J.
- Rueda Garcia, J. L.
- Noci Belda, J.
- Verges Martínez-Meco, T.
- Blanco San Miguel, P.
- Suarez Ferrer, C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Seroprevalence of anti-SARS-CoV-2 antibodies in household domestic ferrets (Mustela putorius furo) in Spain, 2019–2023
Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Seroprevalence of anti-SARS-CoV-2 antibodies in household domestic ferrets (Mustela putorius furo) in Spain, 2019–2023
Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Seroprevalence of anti-SARS-CoV-2 antibodies in household domestic ferrets (Mustela putorius furo) in Spain, 2019–2023
Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!